Pre-treatment serum albumin and mutational burden as biomarkers of response to immune checkpoint blockade

The effects of cytokine and protein stabilizing carriers, such as serum albumin, on tumor response to immune checkpoint blockade (ICB) is not well understood. By examining 1714 patients across 16 cancer types, we found that high pretreatment serum albumin level predicts favorable tumor radiographic...

Descripción completa

Detalles Bibliográficos
Autores principales: Yoo, Seong-Keun, Chowell, Diego, Valero, Cristina, Morris, Luc G. T., Chan, Timothy A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Brief Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8990074/
https://www.ncbi.nlm.nih.gov/pubmed/35393553
http://dx.doi.org/10.1038/s41698-022-00267-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8990074/
https://www.ncbi.nlm.nih.gov/pubmed/35393553
http://dx.doi.org/10.1038/s41698-022-00267-7

Ejemplares similares